Concepedia

Author

Juan Mieres

Sanatorio Otamendi y MiroliORCID

Also Known As

Carlos Fernández-Pereira, Centro CECI., Centro CECI. Buenos Aires y San Isidro., J. Mieres, Jennifier Mieres, Juan MIERES, Juan Mieres, Juan R. Mieres, Juan Ramon Mieres, Kazuhiro Minagawa

70

Publications

489

Citations

12

H-Index

9

Concepts

All Affiliations

Sanatorio Otamendi y MiroliAzienda Ospedaliero-Universitaria CareggiMassachusetts General HospitalCentro de Investigaciones Cardiovasculares
JM

About

Juan Mieres is an author at Sanatorio Otamendi y Miroli specializing in outcomes research, surgery, and percutaneous coronary intervention.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

40

2

Percutaneous Coronary Intervention

2

2

40

3

Diabetes

1

1

28

4

Cardiology

1

1

28

5

Cardiovascular Disease

1

1

28

Juan Mieres

×

8

Publications

250

Citations

8

H-Index

YearCitations

Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry

Alfredo E. Rodríguez, Andrew Maree, Juan Mieres,

European Heart Journal

2007

89

Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.

Alfredo E. Rodríguez, Liliana Grinfeld, Carlos Fernandez‐Pereira,

PubMed

2006

40

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: Results from the DiabEtic Argentina Registry (DEAR)

Juan Mieres, Carlos Fernández‐Pereira, Gustavo Risau,

Cardiovascular revascularization medicine

2012

28

Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk

Antonio Landi, Mirvat Alasnag, Dik Heg,

JAMA Cardiology

2023

28

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

Carlos Haiek, Carlos Fernández‐Pereira, Omar Santaera,

Catheterization and Cardiovascular Interventions

2016

21

Randomized comparison of cost‐saving and effectiveness of oral rapamycin plus bare‐metal stents with drug‐eluting stents: Three‐year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial

Alfredo E. Rodríguez, Alfredo M. Rodriguez–Granillo, David Antoniucci,

Catheterization and Cardiovascular Interventions

2011

18

Efficacy and safety of a double‐coated paclitaxel‐eluting coronary stent: The EUCATAX trial

Alfredo E. Rodríguez, Cesar F. Vigo, Alejandro Delacasa,

Catheterization and Cardiovascular Interventions

2010

14

Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial)

Alfredo E. Rodríguez, Igor F. Palacios, Alfredo M. Rodriguez–Granillo,

The American Journal of Cardiology

2013

12

Page 1